FDA Inspection 871498 — Carter BloodCare

Carter BloodCare — FEI 3005680006

The FDA completed an inspection of Carter BloodCare on March 26, 2014 in Mansfield, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 26, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Mansfield, TX (United States)